Nutrien Ltd (NTR)
Official siteBASIC MATERIALS • AGRICULTURAL INPUTS • NYSE
Market Cap: $33.78B
Last updated: Nov 17, 2026 at 11:06 AM ET
Nutrien Ltd (NTR) Financials: Revenue, Profit and Cash Flow
Nutrien reported revenue of $26.89B for the fiscal year ended Dec 31, 2025, up 3.5% from the year before. That year, net income was $2.27B with a net margin of 8.4%, operating cash flow was $4.08B and free cash flow was $2.04B. The quarter ended Sep 30, 2026 had revenue of $6.06B and net income of $284.00M.
Revenue and Margins
The operating margin was 14.4% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $4.46B, a compound annual rate of 22.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $26.89B | +3.5% | 31.0% | 14.4% | 8.4% |
| Dec 2024 | $25.97B | -10.6% | 29.0% | 11.4% | 2.6% |
| Dec 2023 | $29.06B | -23.3% | 29.2% | 13.3% | 4.3% |
| Dec 2022 | $37.88B | +36.7% | 40.7% | 28.5% | 20.2% |
| Dec 2021 | $27.71B | +32.5% | 34.0% | 17.3% | 11.4% |
| Dec 2020 | $20.91B | +4.1% | 25.1% | 4.3% | 2.2% |
| Dec 2019 | $20.08B | +2.3% | 27.4% | 9.3% | 4.9% |
| Dec 2018 | $19.64B | +331.8% | 27.5% | 2.1% | 18.2% |
| Dec 2017 | $4.55B | +2.0% | 15.3% | 4.6% | 7.2% |
| Dec 2016 | $4.46B | N/A | 18.6% | 10.3% | 7.5% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 236.8% from the year before. In the quarter ended Sep 2026, net income fell 38.8% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26.89B | $25.97B | $29.06B | $37.88B | $27.71B | $20.91B | $20.08B | $19.64B | $4.55B | $4.46B |
| Cost of revenue | $18.54B | $18.44B | $20.58B | $22.46B | $18.30B | $15.67B | $14.58B | $14.24B | $3.85B | $3.63B |
| Gross profit | $8.35B | $7.53B | $8.47B | $15.42B | $9.41B | $5.24B | $5.50B | $5.39B | $694.00M | $830.00M |
| Research and development | $0 | $124.00M | $114.00M | $122.00M | $69.00M | $39.00M | $15.00M | $7.00M | $0 | $0 |
| Operating income | $3.87B | $2.95B | $3.86B | $10.81B | $4.78B | $902.00M | $1.86B | $414.00M | $209.00M | $459.00M |
| Net income | $2.27B | $674.00M | $1.26B | $7.66B | $3.15B | $459.00M | $992.00M | $3.57B | $327.00M | $336.00M |
| EBITDA | $6.15B | $4.21B | $4.88B | $12.78B | $6.58B | $2.89B | $3.67B | $2.02B | $903.00M | $1.16B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.06B | $10.81B | $6.05B | $5.34B | $6.01B | $10.44B | $5.10B | $5.08B | $5.35B | $10.16B | $5.39B | $5.66B |
| Gross profit | $1.86B | $3.25B | $1.65B | $1.89B | $1.96B | $3.17B | $1.32B | $1.58B | $1.50B | $2.91B | $1.54B | $1.77B |
| Operating income | $740.00M | $1.99B | $507.00M | $771.00M | $877.00M | $1.78B | $226.00M | $471.00M | $265.00M | $844.00M | $419.00M | $467.00M |
| Net income | $284.00M | $1.21B | $131.00M | $571.00M | $464.00M | $1.22B | $11.00M | $113.00M | $18.00M | $385.00M | $158.00M | $172.00M |
Balance Sheet
As of Dec 2025, total debt of $11.08B exceeded cash and equivalents by $10.38B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $52.21B | $51.84B | $52.75B | $54.59B | $49.95B | $47.19B | $46.80B | $45.50B | $17.00B | $17.27B |
| Current assets | $14.72B | $13.79B | $14.17B | $16.34B | $13.85B | $11.47B | $10.66B | $11.66B | $3.32B | $1.39B |
| Cash and equivalents | $699.72M | $853.00M | $941.00M | $901.00M | $499.00M | $1.45B | $671.00M | $2.31B | $116.00M | $32.00M |
| Total liabilities | $26.89B | $27.40B | $27.55B | $28.72B | $26.25B | $24.79B | $23.93B | $21.08B | $8.70B | $9.06B |
| Short-term debt | $1.73B | $2.93B | $2.65B | $2.99B | $2.39B | $422.00M | $1.69B | $1.63B | $730.00M | $884.00M |
| Long-term debt | $9.35B | $8.88B | $8.91B | $8.04B | $7.52B | $10.05B | $8.55B | $7.59B | $3.71B | $3.71B |
| Shareholder equity | $25.28B | $24.41B | $25.16B | $25.82B | $23.65B | $22.36B | $22.87B | $24.43B | $8.30B | $8.21B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $52.69B | $53.55B | $54.10B | $52.21B | $51.83B | $53.26B | $53.07B | $51.84B | $51.91B | $52.98B | $53.52B | $52.75B |
| Total liabilities | $26.93B | $27.62B | $28.83B | $26.89B | $26.67B | $28.14B | $29.00B | $27.40B | $26.91B | $27.83B | $28.58B | $27.55B |
| Cash and equivalents | $919.00M | $921.00M | $779.55M | $699.72M | $624.00M | $1.39B | $895.00M | $853.00M | $520.00M | $1.00B | $496.00M | $941.00M |
| Shareholder equity | $25.72B | $25.90B | $25.24B | $25.28B | $25.12B | $25.09B | $24.04B | $24.41B | $24.97B | $25.13B | $24.95B | $25.16B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 50.0% of operating cash flow. Dividends came to 52.9% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.08B | $3.54B | $5.07B | $8.11B | $3.89B | $3.32B | $3.67B | $2.05B | $1.23B | $1.26B |
| Capital expenditures | $2.04B | $2.15B | $2.60B | $2.44B | $1.78B | $1.55B | $1.89B | $1.51B | $651.00M | $893.00M |
| Free cash flow | $2.04B | $1.38B | $2.47B | $5.67B | $2.10B | $1.77B | $1.77B | $545.00M | $574.00M | $367.00M |
| Dividends paid | $1.08B | $1.06B | $1.03B | $1.03B | $1.04B | $1.03B | $1.02B | $952.00M | $330.00M | $809.00M |
| Investing cash flow | -$1.40B | -$2.13B | -$2.96B | -$2.90B | -$1.81B | -$1.20B | -$2.80B | $3.89B | -$652.00M | -$895.00M |
| Financing cash flow | -$2.87B | -$1.45B | -$2.06B | -$4.73B | -$3.00B | -$1.34B | -$2.48B | -$3.71B | -$489.00M | -$424.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$425.00M | $2.48B | -$839.21M | $3.03B | -$439.07M | $2.54B | -$1.08B | $3.12B | -$908.00M | $1.81B | -$487.00M | $4.15B |
| Capital expenditures | $525.00M | $491.00M | $294.86M | $843.85M | $494.68M | $424.00M | $300.00M | $705.00M | $529.00M | $526.00M | $353.00M | $831.00M |
| Free cash flow | -$950.00M | $1.99B | -$1.13B | $2.18B | -$933.75M | $2.11B | -$1.38B | $2.42B | -$1.44B | $1.28B | -$840.00M | $3.32B |
Frequently Asked Questions About NTR
What is Nutrien's annual revenue?
Nutrien reported revenue of $26.89B for the fiscal year ended Dec 31, 2025.
How fast is Nutrien's revenue growing?
Revenue was up 3.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -10.8%.
Is Nutrien profitable?
Yes. Nutrien reported net income of $2.27B for the fiscal year ended Dec 31, 2025, with a net margin of 8.4%.
How much free cash flow does NTR generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $4.08B minus capital expenditures of $2.04B produced free cash flow of $2.04B.
How much debt does Nutrien have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $9.35B, short-term debt of $1.73B and cash and equivalents of $699.72M.
NTR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts